J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 1, 2006

Papers In Press, published online ahead of print August 23, 2006
J. Lipid Res., doi:10.1194/jlr.M600200-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M600200-JLR200v1
47/11/2562    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vedala, A.
Right arrow Articles by Hellerstein, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vedala, A.
Right arrow Articles by Hellerstein, M. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on May 9, 2006
Revised on August 21, 2006
Accepted on August 23, 2006

Contributions from plasma NEFA, diet and de novo lipogenesis-derived fatty acids to fasting VLDL-triglycerides via the delayed secretory pathway in humans

Aruna Vedala, Wei Wang, Richard A. Neese, Mark P. Christiansen, and Marc K. Hellerstein

Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720-3104

Corresponding Author: march{at}nature.berkeley.edu

Newly synthesized hepatic triglyceride (TG) may exit the liver as VLDL-TG immediately or be stored in the cytosol and secreted after a delay. We quantified in humans the contribution from plasma NEFA, diet and de novo lipogenesis (DNL)-derived fatty acids (FA) to fasting VLDL-TG via the immediate and delayed secretory pathways by a stable isotope labeling approach. Five lean, normolipidemic subjects; six obese, hypertriglyceridemic non-diabetic (HPTG) subjects; and six obese, diabetic HPTG subjects were studied. Intravenous [2H31]-palmitate and [1-13C1]- acetate and oral [2H35]-stearate were administered during the 30 hour period preceding an overnight fast. [1,2,3,4-13C4]-palmitate was infused intravenously during the subsequent 12 hr overnight fasting period. The contributions from plasma NEFA via the immediate secretory pathway were 64±15%, 33±6% and 58±2% in control, HPTG and diabetic HPTG groups, respectively. Dietary FA contributed 2.0±0.9%, 2.5±1% and 12±2%, while DNL provided 3±0.3%, 14±3% and 13±4%, in the three groups. The summed delayed pathway contribution from all measured sources was 20±3%, 36±7% and 56±5% in the three groups, leaving unaccounted (unlabeled) contributions of 25±13%, 32±11% and <0%. VLDL-TG production rates and the absolute input rate from the delayed pool were significantly higher in both HPTG and diabetic HPTG than controls. In conclusion, we provide kinetic evidence for an hepatic TG storage pool in humans and document its sources and its importance in HPTG. The turnover time of this pool is shorter and the metabolic sources of TG differ in diabetic HPTG than in non-diabetic HPTG, however. These differences may have therapeutic implications.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Adiels, S.-O. Olofsson, M.-R. Taskinen, and J. Boren
Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1225 - 1236.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. J. Parks, L. E. Skokan, M. T. Timlin, and C. S. Dingfelder
Dietary Sugars Stimulate Fatty Acid Synthesis in Adults
J. Nutr., June 1, 2008; 138(6): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F-F Chong, L. Hodson, A. S Bickerton, R. Roberts, M. Neville, F. Karpe, K. N Frayn, and B. A Fielding
Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 817 - 823.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. K. Hellerstein
Exploiting Complexity and the Robustness of Network Architecture for Drug Discovery
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. P.Y. Koonen, R. L. Jacobs, M. Febbraio, M. E. Young, C.-L. M. Soltys, H. Ong, D. E. Vance, and J. R.B. Dyck
Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity
Diabetes, December 1, 2007; 56(12): 2863 - 2871.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Hodson, A. S.T. Bickerton, S. E. McQuaid, R. Roberts, F. Karpe, K. N. Frayn, and B. A. Fielding
The Contribution of Splanchnic Fat to VLDL Triglyceride Is Greater in Insulin-Resistant Than Insulin-Sensitive Men and Women: Studies in the Postprandial State
Diabetes, October 1, 2007; 56(10): 2433 - 2441.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.